Literature DB >> 2408455

Ketotifen effect on secretion of histamine from basophils and on proliferative response of mononuclear cells of human peripheral blood.

I S Gushchin, A A Serov, A I Zebrev, A M Sapozhnihov, A V Khristenko.   

Abstract

Within the concentrations tested (0.125-1 mM), Ketotifen KT did not release histamine from the basophils, but, depending on dosage, inhibited release induced by anti-IgE antibodies or Con A. KT action developed without a latent period and was maintained for all time intervals used in the experiments (up to 40 min). Cell washing for histamine resulted in a rapid (not longer than 5 min) recovery of their sensitivity to histamine releasers. KT did not affect histamine release induced by cytotoxic releasers (chlorpromazine and melittin). In low concentrations (5 and 50 microM), KT potentiated mononuclear cell (MNC) response to phytohemagglutinin (PHA) evaluated by 3H-thymidine incorporation, and, in high concentrations, blocked it. In doses blocking the proliferative response to PHA, KT also blocked MNC proliferation induced by Con and PWM. Within the tested concentrations, KT inhibited the PHA-induced increase of MNC protein synthesis evaluated by 14C-L-leucine incorporation, and, in high concentrations-blocked it. The obtained findings show that KT does not affect the induction stages of the proliferative response, but rather the stages preceding the cells transmission into the "S-phase". KT action was accompanied by a change in the cells electrophoretic mobility (EPM): in low concentrations (5 microM) KT was found to intensify the cells EPM and in high ones (250-500 microM)-to inhibit the EPM of MNC.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408455

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  4 in total

1.  Ketotifen-induced histamine release, inhibition of histamine secretion and modulation of immune response.

Authors:  I S Gushchin; A I Zebrev
Journal:  Agents Actions       Date:  1986-04

Review 2.  Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.

Authors:  Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

3.  The mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contractures.

Authors:  Michael J Monument; David A Hart; A Dean Befus; Paul T Salo; Mei Zhang; Kevin A Hildebrand
Journal:  J Bone Joint Surg Am       Date:  2010-06       Impact factor: 5.284

4.  Histamine releasing action of calcium ionophore 985-I.

Authors:  I S Gushchin; A I Zebrev; V G Voitenko
Journal:  Agents Actions       Date:  1988-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.